Baxter BioPharma Solutions is pleased to announce the recent completion of the lyophilization capacity expansion at their cytotoxic contract manufacturing facility in Halle (Westfalen), Germany. The facility was expanded to meet the growing demand of the cytotoxic contract manufacturing market. The expansion increased their total cytotoxic lyophilization capacity to four dedicated lyophilizers and over 1,100 square feet.
